Eulerpool Terminal
The edge that pays for itself.
Current Upstream Bio forecasts and price targets in August 2026
Ø Analyst Price Targets
49.47 USD
+582.34 %
Median
45.90 USD
+533.10 %
Max
78.75 USD
Min
35.35 USD
Last Price
7.25 USD
Buy
11
Hold
1
Sell
0
The average target price for Upstream Bio is 49.47 USD. (+582.34 % above the current price)
The median price target of Upstream Bio is 45.90 USD.
Stock analysts from many renowned investment banks are closely examining the Upstream Bio stock. They conclude their professional Upstream Bio stock analyses with a clear recommendation for the Upstream Bio stock. The forecasts and price targets of professional analysts can be a good indicator of how a stock will perform in the next quarter.
| Buy | Hold | Sell | Ø Analyst Price Targets | |
|---|---|---|---|---|
| 2026-03-01 | 11 | 1 | 0 | — |
| 2026-02-01 | 11 | 1 | 0 | 49.47 USD |
| 2026-02-01 | 11 | 1 | 0 | 49.47 USD |
| 2026-01-01 | 11 | 1 | 0 | 49.47 USD |
| 2025-12-01 | 8 | 1 | 0 | 48.96 USD |
| 2025-12-01 | 8 | 1 | 0 | 51.00 USD |
Upstream Bio Stock Forecast 2026: Revenue & Earnings Estimates
Analysts expect the following revenue and earnings for Upstream Bio in the coming fiscal years:
| Fiscal year | Revenue | Net Income | Earnings per share |
|---|---|---|---|
| 2026e | 2.00 M USD | -151.00 M USD | -2.78 USD |
| 2027e | 1.00 M USD | -154.00 M USD | -2.84 USD |
| 2028e | 4.00 M USD | -167.00 M USD | -3.08 USD |